首页> 外国专利> Oncogene expression ntrk1 derivatives in pheochromocytoma PC12 cells and use thereof for screening anti-tyrosine kinase compounds.

Oncogene expression ntrk1 derivatives in pheochromocytoma PC12 cells and use thereof for screening anti-tyrosine kinase compounds.

机译:嗜铬细胞瘤PC12细胞中癌基因表达ntrk1衍生物及其在筛选抗酪氨酸激酶化合物中的用途。

摘要

The present invention provides a system cell culture IN VITRO BASED ON NEURAL CELLS COMPRISING DERIVATIVES oncogenic NRTK1 GENE RECEPTOR NGF (FACTOR OF NERVE GROWTH), and exhibiting neuronal differentiation INDEPENDENT NGF which has a great resemblance to the CELLULAR NGF-induced responses in normal cells, but differs OF THESE ANSWERS FOR PRESENTING CELL DEGENERATION AFTER PROLONGED PERIODS OF FARMING. The present invention further provides expression vectors Eukaryotic cDNAs encoding CONTAINING oncoprotein TRKT1 DERIVED NRTK1, and a method for obtaining such cells NEURAL by transformation with eukaryotic expression vectors encoding oncogenic NTRK1 DERIVATIVES.
机译:本发明提供了基于神经细胞的体外系统细胞培养物,所述神经细胞包含衍生的致癌性NRTK1基因受体NGF(神经生长因子),并且表现出神经元分化独立的NGF,其与正常细胞中细胞NGF诱导的应答非常相似,但在长期耕种后,这些用于提示细胞退化的答案有所不同。本发明进一步提供了表达载体,其编码含有癌蛋白TRKT1的NRTK1的真核cDNA,以及通过用编码致癌NTRK1衍生物的真核表达载体转化而获得这种细胞NEURAL的方法。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号